FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386305879> ?p ?o ?g. }

• W4386305879 abstract "The US Food and Drug Administration approved immune checkpoint inhibitors (immunotherapy) for select cases of head and neck squamous cell carcinoma (HNSCC) in 2016. However, it is unclear whether there are clinical or sociodemographic differences among patients receiving immunotherapy as part of their care. Given the known disparities in head and neck cancer care, we hypothesized that there are differences in receipt of immunotherapy among patients with HNSCC based on clinical and nonclinical characteristics.To characterize clinical and nonclinical factors associated with receipt of immunotherapy among older patients with HNSCC.This retrospective cohort study included patients 65 years or older diagnosed with HNSCC (n = 4860) in a community oncology care setting. Electronic health records from Navigating Cancer were assessed from January 1, 2017, to April 30, 2022.Multivariable logistic regression was used to characterize clinical (tumor stage [localized vs advanced] and anatomical subsite [oropharyngeal vs nonoropharyngeal]) and nonclinical (age, smoking history, race and ethnicity, sex, and marital status) factors associated with receipt of immunotherapy.In the study cohort of 4860 patients, 3593 (73.9%) were men; 4230 (87.0%) were White and 630 (13.0%) were of other races. A total of 552 patients (11.4%) had received immunotherapy. After adjusting for covariates, in the final model, White patients with HNSCC had 80% increased odds of receiving immunotherapy (adjusted odds ratio [AOR], 1.80 [95% CI, 1.30-2.48]) compared with patients of other races. There were no statistically significant differences in the odds of receiving immunotherapy based on age, sex, or smoking history. Patients with nonoropharyngeal disease were significantly more likely to receive immunotherapy than those with oropharyngeal cancer (AOR, 1.29 [95% CI, 1.05-1.59]), as were those with advanced compared with local disease (AOR, 2.39 [95% CI, 1.71-3.34]).The findings of this cohort study suggest that among older patients with HNSCC, White patients may be more likely to receive immunotherapy as part of their care. Equitable access to immunotherapy and other treatment options will reduce cancer-related health disparities and improve survival of patients with HNSCC." @default.
• W4386305879 created "2023-09-01" @default.
• W4386305879 creator A5003148106 @default.
• W4386305879 creator A5018024529 @default.
• W4386305879 creator A5042986144 @default.
• W4386305879 creator A5045205646 @default.
• W4386305879 creator A5055554188 @default.
• W4386305879 creator A5061637798 @default.
• W4386305879 creator A5066013131 @default.
• W4386305879 creator A5066434889 @default.
• W4386305879 creator A5067966408 @default.
• W4386305879 creator A5082072837 @default.
• W4386305879 creator A5089430002 @default.
• W4386305879 creator A5090389591 @default.
• W4386305879 date "2023-08-31" @default.
• W4386305879 modified "2023-10-13" @default.
• W4386305879 title "Differences in Receipt of Immunotherapy Treatment Among Patients With Head and Neck Cancer" @default.
• W4386305879 cites W1858136646 @default.
• W4386305879 cites W1997980031 @default.
• W4386305879 cites W2000949271 @default.
• W4386305879 cites W2069179442 @default.
• W4386305879 cites W2079018735 @default.
• W4386305879 cites W2209450828 @default.
• W4386305879 cites W2401455386 @default.
• W4386305879 cites W2462812966 @default.
• W4386305879 cites W2471185573 @default.
• W4386305879 cites W2485800006 @default.
• W4386305879 cites W2523194272 @default.
• W4386305879 cites W2529484692 @default.
• W4386305879 cites W2732145317 @default.
• W4386305879 cites W2889350033 @default.
• W4386305879 cites W2907928497 @default.
• W4386305879 cites W2911471977 @default.
• W4386305879 cites W2938326907 @default.
• W4386305879 cites W2988556110 @default.
• W4386305879 cites W2999099062 @default.
• W4386305879 cites W3142727253 @default.
• W4386305879 cites W3181441535 @default.
• W4386305879 cites W3189212793 @default.
• W4386305879 cites W3198308916 @default.
• W4386305879 cites W3206288742 @default.
• W4386305879 cites W3208281209 @default.
• W4386305879 cites W4200541737 @default.
• W4386305879 cites W4223914035 @default.
• W4386305879 cites W4226237761 @default.
• W4386305879 cites W4234268713 @default.
• W4386305879 cites W4236488009 @default.
• W4386305879 cites W4239075946 @default.
• W4386305879 cites W4247123733 @default.
• W4386305879 cites W4247797754 @default.
• W4386305879 cites W4250660753 @default.
• W4386305879 cites W4283735762 @default.
• W4386305879 cites W4311633519 @default.
• W4386305879 cites W4377137126 @default.
• W4386305879 doi "https://doi.org/10.1001/jamaoto.2023.2420" @default.
• W4386305879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37651149" @default.
• W4386305879 hasPublicationYear "2023" @default.
• W4386305879 type Work @default.
• W4386305879 citedByCount "0" @default.
• W4386305879 crossrefType "journal-article" @default.
• W4386305879 hasAuthorship W4386305879A5003148106 @default.
• W4386305879 hasAuthorship W4386305879A5018024529 @default.
• W4386305879 hasAuthorship W4386305879A5042986144 @default.
• W4386305879 hasAuthorship W4386305879A5045205646 @default.
• W4386305879 hasAuthorship W4386305879A5055554188 @default.
• W4386305879 hasAuthorship W4386305879A5061637798 @default.
• W4386305879 hasAuthorship W4386305879A5066013131 @default.
• W4386305879 hasAuthorship W4386305879A5066434889 @default.
• W4386305879 hasAuthorship W4386305879A5067966408 @default.
• W4386305879 hasAuthorship W4386305879A5082072837 @default.
• W4386305879 hasAuthorship W4386305879A5089430002 @default.
• W4386305879 hasAuthorship W4386305879A5090389591 @default.
• W4386305879 hasConcept C121608353 @default.
• W4386305879 hasConcept C126322002 @default.
• W4386305879 hasConcept C143998085 @default.
• W4386305879 hasConcept C151956035 @default.
• W4386305879 hasConcept C156957248 @default.
• W4386305879 hasConcept C167135981 @default.
• W4386305879 hasConcept C2776530083 @default.
• W4386305879 hasConcept C2776833033 @default.
• W4386305879 hasConcept C2777701055 @default.
• W4386305879 hasConcept C2780057760 @default.
• W4386305879 hasConcept C71924100 @default.
• W4386305879 hasConcept C72563966 @default.
• W4386305879 hasConceptScore W4386305879C121608353 @default.
• W4386305879 hasConceptScore W4386305879C126322002 @default.
• W4386305879 hasConceptScore W4386305879C143998085 @default.
• W4386305879 hasConceptScore W4386305879C151956035 @default.
• W4386305879 hasConceptScore W4386305879C156957248 @default.
• W4386305879 hasConceptScore W4386305879C167135981 @default.
• W4386305879 hasConceptScore W4386305879C2776530083 @default.
• W4386305879 hasConceptScore W4386305879C2776833033 @default.
• W4386305879 hasConceptScore W4386305879C2777701055 @default.
• W4386305879 hasConceptScore W4386305879C2780057760 @default.
• W4386305879 hasConceptScore W4386305879C71924100 @default.
• W4386305879 hasConceptScore W4386305879C72563966 @default.
• W4386305879 hasLocation W43863058791 @default.
• W4386305879 hasLocation W43863058792 @default.
• W4386305879 hasOpenAccess W4386305879 @default.
• W4386305879 hasPrimaryLocation W43863058791 @default.

• next